PREFORMULATION SCREENING OF REPAGLINIDE FOR TRANSDERMAL ANTI-DIABETIC THERAPY
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 4
Abstract
The aim of the present work is to study the preformulation parameters for Transdermal drug delivery system. The objective of Preformulation study is to generic information useful to the formulater in developing stable and bioavailable dosage form. The use of Preformulation parameter maximizes the chances in formulation an acceptable, safe, efficacious and stable product and at the same time provide the basis for optimization of the drug product quality. Administration of conventional tablets of repaglinide has been reported to exhibit fluctuations in plasma drug levels, resulting either in manifestation of side effects or reduction in drug concentration at the receptor sites also, the maintenance of a constant plasma concentration of a anti-diabetic drug is important in ensuring the desired therapeutic response, again since the half life of repaglinide is 01 hour hence multiple doses of the drug are needed to maintain a constant plasma concentration for a good therapeutic response, and improve patient compliance, hence the objective of the study was made to develop controlled release Transdermal Drug Delivery System of repaglinide using polymer like Eudragit RS 100, Eudragit RL 100 and HPMC, which will controlled the release of drug, increasing the bioavailability of the drug and thus decreasing the dosing frequency of the drug. The Preformulation studies were carried out in terms of test for identification (physical appearance, melting point, and uv spectrophotometer), solubility profile, determination of partition coefficient and quantitative estimation of drug. All the observation and results showed that the repaglinide could serve as suitable candidate for Transdermal drug delivery system that may improve the bioavailability.
Authors and Affiliations
Mithilesh Sahu
Keywords
Related Articles
- EP ID EP293856
- DOI 10.22270/jddt.v7i4.1460
- Views 87
- Downloads 0
FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS FOR ZIDOVUDINE AND LAMIVUDINE COMBINATION USING FRUCTOSE AS OSMOGEN
The present study deals with the development and evaluation of controlled porosity osmotic pump (CPOP) tablets of zidovudine-lamivudine. Wet granulation method was used for the development of core tablets. Core tablets w...
POLYCAPROLACTONE AS DRUG CARRIER FOR AN ANTIFUNGAL AGENT
One of the most suitable and most used biodegradable polymers in particulate drug delivery is Polycaprolactone. This could be attributed to its several important characteristics including its low degradation rate, high p...
DRY POWDER INHALER; SPECIAL EMPHASIS TO FORMULATION, DEVICES, CHARACTERIZATION & PROCESS VALIDATION PROTOCOL: A REVIEW
The therapy was carried out by inhalation of medicinal plants to cure illness of respiratory tract by ancient people. A wide range of dry powder inhaler devices are presently available on the market to convey drugs into...
VALIDATED COLORIMETRIC METHODS FOR THE ESTIMATION OF TENELIGLIPTIN IN TABLETS
Two simple sensitive and precise methods A and B were developed for the estimation of teneligliptin in bulk drug as well as in pharmaceutical dosage form. Method A is based on the formation of a red colored chromogen by...
ADEQUACY OF THE CURRENT RECOMMENDED DOSAGE OF CIPROFLOXACIN IN PRETERM AND TERM NEONATES WITH SEPSIS
Objectives: To determine the percentage of neonates with sepsis, on treatment with standard recommended dose of intravenous ciprofloxacin, who had the serum ciprofloxacin Peak concentration: Minimum inhibitory concentra...